EX-23.1 2 ea127175ex23-1_protara.htm CONSENT OF MARCUM LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Exhibit 23.1

 

Independent Registered Public Accounting Firm’s Consent

 

We consent to the incorporation by reference in this Registration Statement of Protara Therapeutics, Inc. (formerly ArTara Therapeutics, Inc.) on Form S-3MEF pursuant to Rule 462(b) under the Securities Act of 1933, as Amended, of our report dated March 19, 2020, with respect to our audits of the consolidated financial statements of ArTara Subsidiary, Inc. (formerly ArTara Therapeutics, Inc.) as of December 31, 2019 and 2018 and for the years ended December 31, 2019 and 2018, which report is included in Form 8-K/A of Protara Therapeutics, Inc. (formerly ArTara Therapeutics, Inc., which was formerly known as Proteon Therapeutics, Inc.).

 

/s/ Marcum llp

 

Marcum llp

 

New York

September 22, 2020